• "Oh My Sleeping Child" Narcolepsy Type 1 in a 22-Month-Old Boy
• A Dialogue about Vaccine Side Effects: Understanding Difficult Pandemic Experiences
• A letter to the editor regarding "Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis." by Na et al
• A scoping review of the evidence on pharmacological and non-pharmacological interventions for idiopathic hypersomnia
• A systematic review on the contribution of DNA methylation to hearing loss
• Accidental calcium, magnesium, potassium and sodium oxybates (Xywave) overdose: mistiming of a single night's narcolepsy medication leading to respiratory failure requiring mechanical ventilation
• Ageing-related modification of sleep and breathing in orexin-knockout narcoleptic mice
• Allowing ad libitum sleep during overnight polysomnography impacts Multiple Sleep Latency Test results in patients being assessed for hypersomnolence
• Amphetamine and methylphenidate potential on the recovery from stroke and traumatic brain injury: a review
• An Unusual Cause of Increasing Excessive Daytime Sleepiness in a CPAP-treated Obstructive Sleep Apnea Patient
• Are rare heterozygous <em>SYNJ1</em> variants associated with Parkinson's disease?
• Association between cytokines and symptoms of depression and anxiety in patients with type 1 narcolepsy
• Association between human leukocyte antigen class II-DR-DQ and narcolepsy: a case control study
• Association of lifestyle with sleep health in general population in China: a cross-sectional study
• Atypical isolated cataplexy: two case reports and a mini-review
• Autoimmune encephalitis mediated by postvaccination and infection of SARS-CoV-2 in a patient with a narcolepsy type 1
• Autonomic cardiovascular control is unaffected in children referred for assessment of excessive daytime sleepiness
• Awakening Change-Embracing Disability in Medical Training
• Barriers to therapy adherence in narcolepsy
• Cardiovascular Risks in People With Narcolepsy: Expert Panel Consensus Recommendations
• Cataplexy Mistaken for Seizures in a Patient With Undiagnosed Narcolepsy Type I
• Causal relationship between narcolepsy and anxiety: A two-sample Mendelian randomization study
• Challenges in the Management of Narcolepsy in a Resource Limited Setting: A Case Report
• Child Neurology: Common Occurrence of Narcolepsy Type 1 and Myasthenia Gravis
• Comparing the Prevalence of Sleep Disorders Among Underweight, Normal, Overweight, and Obese Adults in Riyadh, Saudi Arabia
• Constructing a cataplexy face prediction model for narcolepsy type 1 based on ResNet-18
• Correction: Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary
• Correlation analysis between HLA-DQA1*0102/DQB1*0602 genotypes and narcolepsy patients in China
• Crosstalk between epitranscriptomic and epigenomic modifications and its implication in human diseases
• CSF dynamics of orexin and beta-amyloid(42) levels in narcolepsy and Alzheimer's disease patients: a controlled study
• Deficiency of P2RY11 causes narcolepsy and attenuates the recruitment of neutrophils and macrophages in the inflammatory response in zebrafish
• Development and validation of a machine learning model for prediction of comorbid major depression disorder among narcolepsy type 1
• Development of a Mindfulness-Based Intervention for Narcolepsy: A Feasibility Study
• Disadvantaged social status contributed to sleep disorders: An observational and genome-wide gene-environment interaction analysis
• Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus Recommendations
• Effects of modafinil on nocturnal sleep patterns in patients with narcolepsy: A cohort study
• Estimating the prevalence and clinical causality of obstructive sleep apnea in paediatric narcolepsy patients
• Eurycoma longifolia (Tongkat Ali) supplementation enhances sleep and wake consolidation in wild-type, but not in narcoleptic mice
• Evaluating routine blood and cerebrospinal fluid samples in narcolepsy patients
• Executive function performance in children and adolescent patients with narcolepsy type 1
• Exploring the association between hypocretin-1 levels and bone mineral content in patients with narcolepsy: A cross-sectional study
• Exploring the bidirectional relationship between sleep disorders and atrial fibrillation: implications for risk stratification and management
• Exploring the correlation between paediatric narcolepsy and serum neurofilament light chain levels: An exploratory study
• Exploring the symptoms and sleep disorders associated with migraines in women of Syria: A cross-sectional observational study
• From past to future: 50 years of pharmacological interventions to treat narcolepsy
• Gender medicine and sleep disorders: from basic science to clinical research
• Guidelines for the assessment and management of residual sleepiness in obstructive apnea-hypopnea syndrome: Endorsed by the French Sleep Research and Medicine Society (SFRMS) and the French Speaking Society of Respiratory Diseases (SPLF)
• Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss
• High-resolution HLA sequencing and hypocretin receptor 2 autoantibodies in narcolepsy type 1 and type 2
• Histamine H₃ Receptor Isoforms: Insights from Alternative Splicing to Functional Complexity
• Hits and misses with animal models of narcolepsy and the implications for drug discovery
• Identifying time-resolved features of nocturnal sleep characteristics of narcolepsy using machine learning
• Immune Reconstitution Inflammatory Syndrome Due to HIV Treatment as a Potential Trigger: A Case Report with Late-Onset Narcolepsy
• Impaired Cognition in Narcolepsy: clinical and neurobiological perspectives
• Improvement in sleep latency with extended-release once-nightly sodium oxybate for the treatment of adults with narcolepsy: Analysis from the phase 3 REST-ON clinical trial
• Improvements in daytime sleepiness and disrupted nighttime sleep with once-nightly sodium oxybate in people with narcolepsy type 1 and type 2: a plain language summary
• In vivo photocontrol of orexin receptors with a nanomolar light-regulated analogue of orexin-B
• Incidence of narcolepsy symptoms after taking COVID-19 vaccines: a Jordanian cross-sectional study
• Increased Risk of New-Onset Hypertension in Patients With Narcolepsy Initiating Sodium Oxybate: A Real-World Study
• Infection, vaccination and narcolepsy type 1: Evidence and potential molecular mechanisms
• Insights from a 10-year Australasian idiopathic hypersomnia patient data registry study
• International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
• Isolated REM Sleep without Atonia Is Not Equivalent to REM Sleep Behavior Disorder in Early-Stage Parkinson's Disease
• Letter to the Editor regarding: "Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary" by R. Rosenberg et al
• Long-term follow-up of symptom and quality of life changes in patients with narcolepsy during and after the COVID-19 pandemic
• Loss of rapid eye movement atonia in rapid eye movement sleep behaviour disorder and narcolepsy
• Machine learning-Based model for prediction of Narcolepsy Type 1 in Patients with Obstructive Sleep Apnea with Excessive Daytime Sleepiness
• Major Alteration Of Motor Control During Rem Sleep In Mice Models Of Sleep Disorders
• Microglia Density and Its Association With Disease Duration, Severity, and Orexin Levels in Patients With Narcolepsy Type 1
• Narcolepsy and pediatric acute-onset neuropsychiatric syndrome: A case report that suggests a putative link between the two disorders
• Narcolepsy and rapid eye movement sleep
• Narcolepsy and risk of traumatic injury: a population-based matched cohort study
• Navigating narcolepsy: exploring coping strategies and their association with quality of life in patients with narcolepsy type 1
• Novel biomarkers derived from the Maintenance of Wakefulness Test as predictors of sleepiness and response to treatment
• Novel Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, Namely, Narcolepsy and Hypersomnia
• Online screening for excessive daytime sleepiness: a feasibility study
• Orexin increases the neuronal excitability of several brain areas associated with maintaining of arousal
• Orexins in apoptosis: a dual regulatory role
• Pattern of sleep disorders among children with autism spectrum disorder
• PET Study of Microglial Activation in Kleine-Levin Syndrome
• Relationship of Suboptimal and Disordered Sleep with Cardiovascular Disease and Its Risk Factors - A Narrative Review
• REM sleep behaviour disorder (RBD): Personal perspectives and research priorities
• Research Progress in the Correlation Between Dopamine and Clinical Characterization of Narcolepsy
• Response to Letter to the Editor Regarding "Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients With Narcolepsy: A Commentary"
• Safety and Efficacy of Lemborexant in Insomnia Patients: Results of a Postmarketing Observational Study of Dayvigo^® Tablets
• Sequential Presentation of Obsessive-Compulsive Disorder and Narcolepsy in a 10-Year-Old Girl With Wolfram Syndrome 1
• Serum N-Glycan Profiling of Patients with Narcolepsy Type 1 Using LC-MS/MS
• Single cell transcriptomics of cerebrospinal fluid cells from patients with recent-onset narcolepsy
• Sleep Disorders' Prevalence and Impact on Academic Performance among Undergraduate Nursing Students in a Selected University, United Arab Emirates
• Sleep regulation and host genetics
• The actigraphic evaluation of daytime sleep in central disorders of hypersomnolence: comparison with polysomnography
• The Changed Nocturnal Sleep Structure and Higher Anxiety, Depression, and Fatigue in Patients with Narcolepsy Type 1
• The electroretinography to identify biomarkers of idiopathic hypersomnia and narcolepsy type 1
• The nature and magnitude of cognitive impairment in narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia: a meta-analysis
• The Promise of Mindfulness-Based Interventions for Narcolepsy
• The relationship between rapid eye movement electromyogram activity and sleep stability in rapid eye movement sleep behavior disorder
• The value of using ELISA to detect orexin-A in cerebrospinal fluid in the diagnosis of narcolepsy
• Type 1 Narcolepsy in Pregnancy: A Case Report and Review of Literature
• Validation and performance of the sleep inertia questionnaire in central disorders of hypersomnolence
• Weight Loss With Once-nightly Sodium Oxybate for the Treatment of Narcolepsy: Analysis From the Phase III Randomized study Evaluating the efficacy and SafeTy of a ONce nightly formulation of sodium oxybate (REST-ON) Trial